Faruqi and Faruqui, LLP Logo
Share this page

Edge Therapeutics, Inc. (EDGE)

NASDAQ:EDGE

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Edge Therapeutics, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Edge Therapeutics, Inc. (“Edge Therapeutics” or the “Company”) (NASDAQ:EDGE). 

Before market open on March 28, 2018, the Company issued a press release announcing “that a pre-specified interim analysis performed on data from the Day 90 visit of the first 210 subjects randomized and treated in the Phase 3 NEWTON 2 study of EG-1962 in adults with aneurysmal subarachnoid hemorrhage (aSAH) demonstrated a low probability of achieving a statistically-significant difference compared to the standard of care in the study’s primary endpoint[.]”  Furthermore, the Company stated that “[t]he independent Data Monitoring Committee (DMC) recommended that the study be stopped based on its conclusion that the study has a low probability of meeting its primary endpoint” and that the Company “has decided to discontinue the NEWTON 2 study[.]” 

The Phase 3 NEWTON 2 study compared the efficacy and safety of EG-1962, a novel polymeric microparticle containing nimodipine suspended in a diluent of sodium hyaluronate designed to be administered through an external ventricular drain (EVD), to standard of care oral nimodipine in adult patients with aneurysmal subarachnoid hemorrhage (aSAH).

On this news, Edge Therapeutics’ share price declined significantly, causing harm to investors.

If you invested in Edge Therapeutics stock or options and would like to discuss your legal rights, please fill out the form below.  There is no cost or obligation to you.  You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

Contact Us

To contact Faruqi & Faruqi, LLP please call (877) 247-4292 or (212) 983-9330, or please
fill out the form below and a Firm representative will contact you.

  • Case:
    Edge Therapeutics, Inc. (EDGE)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 03/28/2018

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.